Drugmakers are slow to prove medicines that got a fast track to market really work
Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.
(Image credit: Jovelle Tamayo for NPR)
0 Response to "Drugmakers are slow to prove medicines that got a fast track to market really work"
Post a Comment